CD8A and Alzheimer disease: Tissue-Resident Memory T cells (TRMs), particularly CD4+ and CD8+ TRM subsets expressing CD69 and/or CD103, have been increasingly recognized as key drivers of disease persistence and recurrence in AD 32,33.